XMD8-92

CAS No. 1234480-50-2

XMD8-92( XMD8-92 | XMD-8-92 | XMD 8-92 | XMD892 )

Catalog No. M10935 CAS No. 1234480-50-2

XMD8-92 is a potent and selective BMK1/ERK5 inhibitor with Kd of 80 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 61 In Stock
25MG 120 In Stock
50MG 222 In Stock
100MG 372 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    XMD8-92
  • Note
    Research use only, not for human use.
  • Brief Description
    XMD8-92 is a potent and selective BMK1/ERK5 inhibitor with Kd of 80 nM.
  • Description
    XMD8-92 is a potent and selective BMK1/ERK5 inhibitor with Kd of 80 nM.
  • In Vitro
    Cell Viability Assay Cell Line:HMEC, A549 and HeLa cells Concentration:0.16, 0.32, 0.63, 1.25, 2.5 or 5 μM Incubation Time:48 hours Result:Inhibited the proliferation of HMEC and cancer cells.
  • In Vivo
    Animal Model:HeLa Xenograft Model (6-week-old Nod/Scid mice)Dosage:50 mg/kg Administration:I.p.; twice a day for 28 days Result:Significantly inhibited the growth of the xenografted human tumors.
  • Synonyms
    XMD8-92 | XMD-8-92 | XMD 8-92 | XMD892
  • Pathway
    Others
  • Target
    BMI-1
  • Recptor
    BMI-1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1234480-50-2
  • Formula Weight
    474.55
  • Molecular Formula
    C26H30N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 73 mg/mL warmed (153.82 mM)
  • SMILES
    O=C1N(C)C2=CN=C(NC3=CC=C(N4CCC(O)CC4)C=C3OCC)N=C2N(C)C5=CC=CC=C15
  • Chemical Name
    2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sureban SM, et al. Y Lett. 2014 , 351(1), 151-16
molnova catalog
related products
  • XMD8-92

    XMD8-92 is a potent and selective BMK1/ERK5 inhibitor with Kd of 80 nM.

  • PTC-028

    PTC-028 (PTC028) is a novel potent, selective, orally bioavailable BMI-1 inhibitor with potent anti-MM activity against primary MM cells (IC50=10-100 nM).

  • AG 555

    AG 555 is an EGFR tyrosine kinase inhibitor.